Prostate Cancer

If you or a loved one are seeking treatment for prostate cancer, please call us:


Prostate Cancer Treatment with CyberKnife® 

Although prostate cancer is the second leading cause of cancer death in American men, the good news is that 95% of all cases are detected when the disease is confined to the prostate and treatment is most successful.

In many cases, especially when a patient is not a good candidate for surgery, prostate cancer can be effectively treated with targeted radiation known as stereotactic body radiation therapy (SBRT). At HOACNY we deliver SBRT with our non-surgical CyberKnife® system. 

Click here for detailed information about CyberKnife® treatment for prostate cancer, and for answers to the most common questions we receive, click on the videos below. 

Video FAQs with Local HOACNY Patient
  • Acute urinary and rectal side effects are brief, lasting days to weeks as opposed to months.
  • Studies show the CyberKnife® system provides excellent prostate cancer survival rates superior to conventional radiation therapy.
  • Treatments are totally non-invasive, outpatient procedures that do not require general anesthesia, hospitalization, or long recovery time.
  • Complete course of treatment is just 5 treatment days versus 45 days for traditional radiation therapy.
  • During Treatments: To enhance precision, CyberKnife® automatically corrects for natural body movements; a patient wears his own clothes; a patient does not need to fill and hold his bladder on the table.
Is CyberKnife® Treatment (SBRT) Covered by Private Insurance and Medicare?

Stereotactic body radiation therapy (SBRT) treatment for prostate cancer is covered by Medicare in all 50 states and the District of Columbia. In addition, most of our private insurance payers cover SBRT treatment for prostate cancer. It is always best to check your insurance policy and if applicable, be sure to review your employee contract to determine if your insurance coverage benefits are limited.